MetaCap

Precision Optics Corporation Inc. (POCI)

NASDAQ: POCIHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

4.12+0.0573 (+1.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

POCI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$45.30M
EPS (TTM)
-$0.25
52-week range
3.55 – 6.15
Day range
4.05 – 4.23
Volume / Avg
34.08K / 43.00K
Beta
—

52-week range

$3.55$6.15

POCI stock today

Precision Optics (POCI) closed at $4.12 on Nov 20, up 1.41% (+$0.0573), versus the S&P 500's 3.70% decline. Shares are 33.0% below their 52-week high of $6.15, set on Jun 12, 2026 and 16.1% above the 52-week low of $3.55, in the middle of the past year's range. POCI is down 1.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 10.4%.

Precision Optics has posted a net loss over the last twelve months (EPS of -$0.25), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Precision Optics

Company profile

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Dr. Joseph N. Forkey
Headquarters
Gardner, MA
Employees
108
Website
poci.com

Financial highlights

Full financials

In fiscal 2026, Precision Optics generated $31.5 million in revenue, up 65.2% from fiscal 2025. Precision Optics reported a net loss of $3.6 million, compared with a loss of $5.8 million a year earlier. Gross margin was 17.2% (down from 17.8%) and operating margin -11.1%.

Precision Optics annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$31.53M$19.09M$19.10M$21.04M$15.68M
Growth+65.16%-0.07%-9.22%+34.23%+46.87%
Net income$-3.63M$-5.78M$-2.95M$-144.61K$-928.42K
EPS (diluted)$-0.43$-0.85$-0.49$-0.03$-0.18

Analyst forecast

Forecast

Consensus (1 analysts)

strong_buy

Avg. price target

$8.00+94.17%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 16, 2026
EPS actual vs est.
$-0.21 vs —

POCI news

All POCI news

Precision Optics peers

Health Care sector
POCI peer companies
CompanyPrice% ChgMarket capCompare
ECORelectroCore Inc.4.42-8.87%$40.78Mvs POCI
OMOutset Medical Inc.2.81-3.44%$53.03Mvs POCI
HYPRHyperfine Inc. Class A0.5465+4.27%$57.96Mvs POCI
NRXSNeuraxis Inc.4.22-6.22%$59.90Mvs POCI
QTIQT Imaging Holdings Inc.1.92+2.67%$28.21Mvs POCI
ITOCiTonic Holdings Ltd Class A1.59+6.00%$11.63Mvs POCI
IRIXIRIDEX Corporation0.4449-4.59%$7.92Mvs POCI
NDRAENDRA Life Sciences Inc.3.58-3.38%$5.36Mvs POCI

Indexes, lists and sector

Precision Optics stock FAQ

What is Precision Optics's stock price today?

POCI last traded at $4.12 as of Nov 20, 4:00 PM EST, up 1.41% on the day. Prices are delayed at least 15 minutes.

Does Precision Optics pay a dividend?

No. Precision Optics does not currently pay a regular cash dividend.

Who is Precision Optics's CEO?

Dr. Joseph N. Forkey is the chief executive officer of Precision Optics Corporation Inc., which has about 108 employees.

Has POCI ever split its stock?

Yes. The most recent POCI stock split was a 1-for-3 split on Nov 2, 2022, one of 3 splits on record.

What is the POCI 52-week high?

The 52-week high for POCI is $6.15 and the 52-week low is $3.55. The stock is currently 33.0% below its high.

Compare POCI